Shell Asset Management’s HilleVax HLVX Stock Holding History

Shell Asset Management’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,441	Closed	-$41K	–	1285
2022 Q4	$41K	Buy	+2,441	New	+$44.1K	﹤0.01%	1286

Other funds holding HLVX

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Shell Asset Management's HLVX Position: Q1 2023 in Review

Shell Asset Management sold out of HilleVax (HLVX) in Q1 2023, closing a stake of 2,441 shares — an estimated $41K sold.

Shell Asset Management first reported a position in HLVX in Q4 2022 and held it in 1 quarter. The position peaked at $41K in Q4 2022. 61 funds tracked by Wall St. Rank hold HLVX as of Q1 2023.

Shell Asset Management reported no remaining HilleVax position as of Q1 2023 after selling out during the quarter.
Shell Asset Management sold 2,441 HilleVax shares in Q1 2023, an estimated $41K.
Shell Asset Management first reported a position in HilleVax in Q4 2022 and held it in 1 quarter.
Shell Asset Management's HilleVax position peaked at $41K in Q4 2022.
61 funds tracked by Wall St. Rank held HilleVax as of Q1 2023.

Based on Shell Asset Management's 13F filing for Q1 2023, filed 15 May 2023.